跳至主要内容
临床试验/NCT06009523
NCT06009523招募中不适用

Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation in Treatment-resistant Depression : a Pilot Study

Centre Hospitalier Henri Laborit2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年10月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
2
主要终点
Change from Baseline in suicidal ideation on the Scale for Suicide Ideation (SSI) at "Day 19"

研究概览

简要总结

The main objective of this study is to demonstrate that 15 transcranial direct current stimulation (tDCS) sessions of 30 minutes at 2 mA intensity are effective to reduce suicidal ideation

详细描述

After being informed about the study and potential risks, all patients giving written informed consent will undergo a screening visit to determine eligibility for study entry. Patient who meet the eligibility requirements be able to start the 15 tDCS sessions at the rate of one session per day. After the last session, patients will perform three follow-up visits on D19, D49 and D79

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18 years
  • Written informed consent
  • Diagnosis of recurrent or isolated depressive episode according to DSM IV criteria (A.P.A. 1994).
  • Stable antidepressant treatment for 3 weeks
  • MADRS score ≥ 20
  • SSI score > 3
  • Subject affiliated to a health insurance system
  • Woman with effective contraception and agreeing to maintain it throughout the study period.

排除标准

  • Depression with psychotic features Axis I (DSM IV) co-morbid diagnosis of schizophrenia, alcohol and/or other substance dependence (or abuse) (lifetime)
  • Patient who has already undergone an electroconvulsive therapy course for the current episode and does not respond to this treatment
  • Patient deprived of liberty
  • Patient with high suicide risk (item 10 MADRS > 4) in the absence of hospitalization
  • Contraindication to tDCS: intracerebral metallic implant (with the exception of dental implants), cardiac pacemaker, active or non-implanted devices in the region of the head, acute eczema in the planned stimulation area
  • Pregnant, parturient or breastfeeding woman
  • Simultaneous participation in another interventional research

结局指标

主要结局

Change from Baseline in suicidal ideation on the Scale for Suicide Ideation (SSI) at "Day 19"

时间窗: Baseline and "Day 19"

The main judgment criterion is the evolution of suicidal ideation which is evaluated by the Beck Scale for Suicide Ideation (SSI) between Baseline and "Day 19"

次要结局

  • Change from Baseline of clinical response defined by the MADRS (Montgomery and Asberg depression scale) at "Day 19" post-tDCS sessions(Baseline and "Day 19")
  • Change from Baseline of clinical response defined by the MADRS (Montgomery and Asberg depression scale) at "Day 49" post-tDCS sessions(Baseline and "Day 49")
  • Change from Baseline of clinical response defined by the MADRS (Montgomery and Asberg depression scale) at "Day 79" post-tDCS sessions(Baseline and "Day 79")
  • Change from Baseline in quality-of-life assessed by the SF36 (Short Form (36) Health Survey) at "Day 19" post-tDCS sessions(Baseline and "Day 19")
  • Change from Baseline in quality-of-life assessed by the SF36 (Short Form (36) Health Survey) at "Day 79" post-tDCS sessions(Baseline and "Day 79")
  • Change from Baseline in suicidal ideation assessed by the implicit association test at "Day 19" post-tDCS sessions(Baseline and "Day 19")
  • Change from Baseline in suicidal ideation assessed by the implicit association test at "Day 49" post-tDCS sessions(Baseline and "Day 49")
  • Change from Baseline in quality-of-life assessed by the SF36 (Short Form (36) Health Survey) at "Day 49" post-tDCS sessions(Baseline and "Day 49")
  • Change from Baseline in suicidal ideation assessed by the implicit association test at "Day 79" post-tDCS sessions(Baseline and "Day 79")

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验